|
June 1-5
FOCIS 2006,
San Francisco Marriott.
FOCIS is now accepting abstracts for FOCIS 2006, the premier meeting
in translational immunology! Abstracts must be submitted electronically,
via the FOCIS Web site, www.focisnet.org. The deadline to submit
an abstract is January 20,2006. There will be no late-breaking abstract
deadline.
Click here to view the FOCIS 2006 Call for Abstracts
Registration Now Open: Headquarters Hotel Discounts Available!
Registration is now open for FOCIS 2006, June 1-5 at the San Francisco
Marriott. Register before April 15 to receive reduced advance registration
rates.
Registration discounts are also available for booking your room
at the FOCIS 2006 Headquarters Hotel! Simply log onto www.focisnet.org
to make a reservation at the San Francisco Marriott. Use your Marriott
confirmation number when registering for FOCIS 2006 to qualify for
the Headquarters Hotel Discount.
A special trainee rate of $139 available at the San Francisco Marriott,
in addition to an excellent general delegate rate of $184. Trainee
rooms are limited. Book your room now!
Preliminary Program Online Now Log on now to preview the outstanding
scientific program planned for FOCIS 2006. To register and for more
information, visit www.focisnet.org.
Updates will be posted continuously as speakers and sessions are
confirmed.
Questions? Please contact:
FOCIS Executive Office, Megan M. Kelley, Meetings Manager
555 E. Wells St., Suite 1100 Milwaukee, WI 53202
Phone: (414) 918-3192
Fax: (414) 276-3349
E-mail: mkelley@focisnet.org
June 9th
Avian Disease, Diagnosis and Treatment
A one day meeting at Birkbeck college in London. For more information
email enquiries@euroscicon.com
or go to https://www.regonline.co.uk/avian
June 16th,
Assigning gene function -
novel technologies and high throughput.
Birkbeck College, London
This will be an exciting meeting which will cover novel genomic
technologies and the use of bioinformatics in high throughput data
analysis. It will feature academic and industry seminars.
For more information see https://www.regonline.co.uk/genefunction
For General enquiries email: enquiries@euroscicon.comenquiries@euroscicon.com
We seek CPD accreditation from the IBMS for all our meetings
16-17 JUNE 2006
European Perspectives in
Inflammatory Bowel Disease Congress
Lisbon, Portugal
Educationally approved by the European Crohns and Colitis Organization
This meeting will serve as a premier forum where specialists in
the inflammatory bowel diseases, leading gastroenterologists, and
practicing clinicians can review the state of the art and share
the newest advances in the multidisciplinary management of the inflammatory
bowel diseases. The congress will focus on overview lectures by
widely recognized international experts complemented with debate
sessions and case discussions.
This forum of leading clinicians and researchers will present expert
opinions that will contribute to advances in the management of your
IBD patients.
SC I E N T I F I C A G E N D A
Friday, 16 June 2006
08:50 Welcome and introduction
Session I: Pathogenesis in practice
9:00 IBD genetics: quo vadis? Derek Jewell, Oxford
9:30 The bacterial - epithelial interface. Philippe Marteau, Paris
10:00 Serological markers: Hope or expectation? Severine Vermeire,
Leuven
10:30 Prospecting with bioflora. Paolo Gionchetti, Bologna
11:00 Break
Session II: Daily dilemmas in IBD
11:30 5-ASA in IBD: Actions and indications. Eduard F. Stange,
Stuttgart
11:50 Rapidly metabolized steroids. Sandro Ardizzone, Milan
12:10 Thiopurines: Intolerance, response and failure. Marc Lémann,
Paris
12:30 Infliximab: What to do when response is lost. Geert DHaens,
Leuven
12:50 Perianal Crohns: A combined approach. Tom Öresland,
Gothenberg
13:10 Lunch break
Session III: Advances in diagnostic approaches
to IBD
14:30 MR enteroclysis. Andreas Schreyer, Regensberg
14:50 Capsule enteroscopy in IBD Tony Morris, Liverpool
15:10 Pathological pitfalls Bryan Warren, Oxford
15:30 Chromoendoscopy and endomicroscopy for detecting dysplasia.
Ralf Kiesslich, Mainz
15:50 Does the diagnostic approach differ in adolescents? Johanna
C. Escher, Rotterdam
16:15 Break
Session IV: Debates: Controversies in
IBD 1
DEBATE 1:
16:45 Case studies. Simon A. Jackson, Plymouth, Simon P. Travis,
Oxford, Bryan Warren, Oxford, and Alistair Windsor, London
DEBATE 2:
17:30 Pro: Early surgery is the best treatment for ileocaecal Crohns
disease
Alistair Windsor, London
17:40 Con: Medicine is the best treatment for ileocaecal Crohns
disease
Jeremy Sanderson, London
17:50 Question and answer and panel discussion
18:00 Adjourn
Saturday, 17 June 2006
Session V: Developing New Therapies for
IBD
9:00 Immune dysregulation in IBD. Richard P. MacDermott, Albany,
New York
9:30 New horizons in ulcerative colitis Daan Hommes, Amsterdam
10:00 New horizons in Crohns disease. Juergen Schoelmerich,
Regensburg
10:30 Break
11:00 5-ASA chemoprevention of colorectal cancer. Janusz A. Jankowski,
Leicester
11:30 Does our current therapy change the natural history of IBD?
What to do for low grade dysplasia? Steve Itzkowitz, New York,
New York
12:00 State of the art lecture: Novel therapeutic targets. Yehuda
Chowers, Tel Aviv
12:30 Lunch break
Session VI: Debates: Controversies in
IBD 2
DEBATE 3:
14:00 Step up therapy for Crohns disease. Jonathan M. Rhodes,
Liverpool
14:10 Top down therapy for Crohns disease. Daan Hommes,
Amsterdam
14:20 Question and answer and panel discussion
DEBATE 4:
14:50 Pro:Infliximab is appropriate for ulcerative colitis. Geert
DHaens, Leuven
15:00 Con: Infliximab is not appropriate for ulcerative colitis.
Simon P. Travis, Oxford
15:10 Question and answer and panel discussion
15:40 Concluding remarks
Friday 16 June 2006
VASCULAR DEVELOPMENT
The Novartis Foundation, The
Royal Society of Medicine & Physiological Society
The Clore Management Centre,
Birkbeck College,
Malet Street, London WC1, on Friday 16 June 2006.
The programme for this meeting has been organized around four main
topics: the cell biology of blood vessel formation, the genetics
of blood vessel formation, embryonic blood vessel formation in different
animal systems, and the mutual signalling between blood vessels
and tissue cells. With the participation of vascular biologists,
cell biologists and developmental biologists, it is hoped that the
meeting will reveal much new and exciting work in this area, help
to identify and stimulate promising new research directions and
encourage continuing and new collaborations between investigators.
Enquiries/registrations at http://www.rsm.ac.uk/academ/xz-vascular.htm.
Venue location details can be found at
http://www.bbk.ac.uk/bbk/findingbirkbeck/maps/immediateareawebmap.html
Registration fees are £115.00 or £95.00 for RSM Fellows
or
Physiological Society Members, or £25.00 for students. (includes
refreshments and lunch. Space is limited therefore early registration
is recommended. Please note the programme may be subjectto change.
Website: www.novartisfound.org.uk
June 20, 2006
Developing Technologies In
Human Cytokine Detection
Birkbeck College, London
Detection of human cytokines is often at the heart of human disease
studies, but the multitude of techniques involved, and their complexity
can make finding the right technique difficult. This meeting will
give an insight into the latest advances in both established techniques,
such as ELISPOT and FACS and the more recently developed mulitplex
technology for both genes and proteins, such as the Luminex system.
Talks will be given by both the companies developing these techniques
and the academics using them.
For more information see http://www.regonline.co.uk/cytokine
For General enquiries email: enquiries@euroscicon.com
We seek CPD accreditation from the IBMS for all our meetings
June 18-22, 2006.
XIV International Symposium
on Atherosclerosis
Rome, Italy
The triennial series of International Symposia on Atherosclerosis
(ISA), held under the auspices of the International Atherosclerosis
Society (IAS), offers the worlds largest and most prestigious
forum for the presentation of new research and clinical findings
on arterial disease.
These meetings, attended by thousands of specialists interested
in atherosclerosis and related cardiovascular diseases provide the
ideal setting for presentation of the most relevant and important
findings in experimental research and in the clinic. The most recent
symposia have been held in Paris (1997), Stockholm (2000) and Kyoto
(2003). Rome will be the site of the Symposium in 2006.
The Scientific Program Committee of the Symposium to be held in
2006, with advice from the IAS Executive Board and from the International
Advisory Board, will develop a high-quality program. This program
will reflect the growth of this field, both in traditional areas
and in new areas of both basic and clinical science where the most
exciting discoveries are foreseen.
We all have one dream: to provide the International Atherosclerosis
Society and the international scientific community with an exciting,
innovative, and scientifically oriented Symposium in an environment
that will foster old friendships and new collaborations with as
many people from new and emerging countries as possible: good health
and proper health care are the rights of all individuals.
We all look forward to welcoming you to Rome!
More details at:
http://www.isa2006.org/
June 23
Non-Mammalian Models for
Systems Biology
Birkbeck College, London
Model organisms have a long history of underpinning research into
basic biological processes from the fundamental mechanisms of genetics
to the detailed molecular understanding of developmental processes.
In the post genome era several of the well established models are
now serving as templates for systems level research. Compact genomes
and well-established genomics resources, coupled with excellent
genetics, facilitate the development of experimental and computational
methods that are more widely applicable to, for example, the development
of systems approaches in mammals. The meeting aims to demonstrate
how whole-genome and systems level approaches are progressing with
key model systems covering the major non-mammalian species.
For more information see https://www.regonline.co.uk/nonmam
For General enquiries email: enquiries@euroscicon.com
We seek CPD accreditation from the IBMS for all our meetings
|